Inici › Malalties pulmonars intersticials › Illinois › Chicago
Assaigs clínics de Malalties pulmonars intersticials a Chicago, IL
12 estudis de Malalties pulmonars intersticials busquen participants en centres de Chicago i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Pulmonary Fibrosis Foundation Community Registry
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Pulmonary Fibrosis Foundation, Chicago
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
ReclutantFase 2/3
- GSK Investigational Site, Chicago
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Reclutant
- Northwestern University, Chicago
- University of Illinois Health, Chicago
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
ReclutantFase 3
- Northwestern University, Chicago
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
ReclutantFase 2
- Clinical Research Site, Chicago
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
ReclutantEstudi observacional
- Northwestern University, Chicago
Platform Clinical Study for Conquering Scleroderma
ReclutantFase 2
- The University of Chicago Medical Center (UCMC), Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
ReclutantFase 2/3
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
ReclutantEstudi observacional
- University of Chicago, Chicago
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
ReclutantFase 3
- Northwestern Memorial Hospital, Clinical Research Unit, Chicago
- Rush University Medical Center Outpatient Pulmonary Clinic, Chicago
- UI Health Hospital, Chicago
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
ReclutantEstudi observacionalVoluntaris sans benvinguts
- University of Chicago, Chicago
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
ReclutantFase 2
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
Assaigs de Malalties pulmonars intersticials en altres ciutats
- New York City, NY18 estudis
- Philadelphia, PA16 estudis
- Los Angeles, CA14 estudis
- Kansas City, KS13 estudis
- Durham, NC13 estudis
- Charleston, SC13 estudis
- Houston, TX12 estudis
- Ann Arbor, MI11 estudis
- Aurora, CO11 estudis
- Phoenix, AZ9 estudis
- Salt Lake City, UT9 estudis
- Boston, MA9 estudis
Altres estudis a Chicago
- Càncer de pulmó de cèl·lules no petites61 estudis
- Càncer de mama58 estudis
- Càncer (tots els tipus)51 estudis
- Càncer metastàtic45 estudis
- Càncer de pròstata45 estudis
- Obesitat41 estudis
- Càncer de pulmó41 estudis
- Càncer d'ovari36 estudis
- Ictus34 estudis
- Càncer colorrectal33 estudis
- Insuficiència cardíaca31 estudis
- Sobrepès28 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.